Загрузка...
Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents
Histone deacetylases (HDACs) can regulate expression of tumor suppressor genes and activities of transcriptional factors involved in both cancer initiation and progression through alteration of either DNA or the structural components of chromatin. Recently, the role of gene repression through modula...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2010
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2827364/ https://ncbi.nlm.nih.gov/pubmed/20132536 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-8722-3-5 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|